JP2018505666A5 - - Google Patents

Download PDF

Info

Publication number
JP2018505666A5
JP2018505666A5 JP2017534355A JP2017534355A JP2018505666A5 JP 2018505666 A5 JP2018505666 A5 JP 2018505666A5 JP 2017534355 A JP2017534355 A JP 2017534355A JP 2017534355 A JP2017534355 A JP 2017534355A JP 2018505666 A5 JP2018505666 A5 JP 2018505666A5
Authority
JP
Japan
Prior art keywords
sfb
strain
genetically modified
culture
eukaryotic host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017534355A
Other languages
English (en)
Japanese (ja)
Other versions
JP6963999B2 (ja
JP2018505666A (ja
Filing date
Publication date
Priority claimed from PCT/IB2014/067285 external-priority patent/WO2016103005A1/en
Application filed filed Critical
Publication of JP2018505666A publication Critical patent/JP2018505666A/ja
Publication of JP2018505666A5 publication Critical patent/JP2018505666A5/ja
Application granted granted Critical
Publication of JP6963999B2 publication Critical patent/JP6963999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017534355A 2014-12-23 2015-12-23 セグメント細菌のインビトロ培養法 Active JP6963999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2014/067285 2014-12-23
PCT/IB2014/067285 WO2016103005A1 (en) 2014-12-23 2014-12-23 Method of culturing segmented filamentous bacteria in vitro
PCT/IB2015/059948 WO2016103217A1 (en) 2014-12-23 2015-12-23 Method of culturing segmented filamentous bacteria in vitro

Publications (3)

Publication Number Publication Date
JP2018505666A JP2018505666A (ja) 2018-03-01
JP2018505666A5 true JP2018505666A5 (cg-RX-API-DMAC7.html) 2018-09-20
JP6963999B2 JP6963999B2 (ja) 2021-11-10

Family

ID=52462962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017534355A Active JP6963999B2 (ja) 2014-12-23 2015-12-23 セグメント細菌のインビトロ培養法

Country Status (6)

Country Link
US (2) US10435665B2 (cg-RX-API-DMAC7.html)
EP (1) EP3237602B1 (cg-RX-API-DMAC7.html)
JP (1) JP6963999B2 (cg-RX-API-DMAC7.html)
CN (1) CN107429222B (cg-RX-API-DMAC7.html)
AU (1) AU2015370419B2 (cg-RX-API-DMAC7.html)
WO (2) WO2016103005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro
CN106011281B (zh) * 2016-07-19 2019-04-23 浙江大学 肠道分节丝状菌鞭毛蛋白的检测方法
DE102018213030A1 (de) * 2018-08-03 2020-02-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Behandlung von Immunerkrankungen durch die antikörpervermittelte Neutralisierung spezifischer Darmbakterien
WO2021155229A1 (en) * 2020-01-31 2021-08-05 Iowa State University Research Foundation, Inc. Gut bacterium-based treatment to increase poultry gut health and food safety
CA3218163A1 (en) 2021-05-17 2022-11-24 Anne PALERMO Food product comprising a co-culture of bacteria and fungi
WO2026011048A1 (en) * 2024-07-03 2026-01-08 Ohio State Innovation Foundation Commensal bacterial antigen as a therapeutic agent for cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120276149A1 (en) * 2009-10-15 2012-11-01 Dan Littman Methods for modulating bacterial infection
EP2556835B1 (en) * 2010-02-10 2015-08-05 Japan Eco-Science Co. Ltd. Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
MX369877B (es) 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro

Similar Documents

Publication Publication Date Title
Bahey-El-Din Lactococcus lactis-based vaccines from laboratory bench to human use: an overview
CN104894021B (zh) 一种副干酪乳杆菌及其应用
WO2018117263A9 (en) Compositions and methods for the induction of cd8+ t-cells
JP2012526755A (ja) 経管栄養法のためのプロバイオティクス含有モジュール
TW202003834A (zh) 用於誘導cd8+t細胞的組成物及方法
JP4942831B2 (ja) 抗アレルギー用組成物
Del Carmen et al. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model
CA2915673C (en) Immunotherapy composition and use thereof
CN107810264A (zh) 适于保护微生物的组合物
ES2407150T3 (es) Bacteria ácido láctica novedosa con actividad anti-alérgica, agente anti-alérgico, alimento y composición farmacéutica que comprenden, cada uno de ellos, la bacteria ácido láctica, y proceso para la producción del agente anti-alérgico
US20250213673A1 (en) Compositions and methods
CN108348559A (zh) 用于生产共轭亚油酸的副干酪乳杆菌、含有其的营养制剂和药物制剂及其用途
US20190175670A1 (en) Postbiotic-based composition for treatment of ocular inflammation
CN108779433A (zh) 属于开菲尔乳杆菌种的细菌菌株在用于产生和/或维持体内稳态状态的儿科学中的应用
US20130224167A1 (en) Non-replicating probiotic bacteria and prevention or treatment of infections to reduce absence from school or daycare
Patil et al. Engineered bacteria: general overview as therapeutic agent and a novel drug delivery system
CA3090043A1 (en) Postbiotic-based composition for the modulation of immune system activation and protection of mucosal barriers
JP5740613B2 (ja) 疾患の予防改善剤、持久力向上剤、抗疲労剤、並びにそれらを用いた医薬品および飲食品
Shin et al. Assessment of cell adhesion, cell surface hydrophobicity, autoaggregation, and lipopolysaccharide-binding properties of live and heat-killed Lactobacillus acidophilus CBT LA1
Yamamoto et al. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model
KR102305076B1 (ko) 용암해수 유래 천연 미네랄 코팅 프로바이오틱스의 제조방법 및 이를 이용한 용암해수 유래 천연 미네랄 코팅 프로바이오틱스 분무건조 제제
CN102732442A (zh) 一种不含抗性标记的猪霍乱沙门氏菌双基因缺失菌及其应用
Chassard et al. Probiotics and health claims: challenges for tailoring their efficacy.
Podder et al. Efficacy of bacteria in cancer immunotherapy: special emphasis on the potential of mycobacterial species
Salvador-Mira et al. Erythrocyte-targeted recombinant subunit vaccine: A novel approach to improve viral vaccines in fish